MT
MetaVia Inc.
MTVA · NASDAQ
$1.67 -0.60% (-$0.01)
1M +13.07%
Market Cap $3.68M
P/E Ratio -
Div. Yield -
ROE 209.67%
Bulios Fair Price
$2.18
30.5% upside
Current Price
$1.67
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MTVA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 0.54x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 37.41%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 213.33%
ROE 209.67%
ROA 108.85%
Debt
100 /100
Low Debt/Equity 0.03x
Current ratio 2.06x
Int. coverage N/A
Stability
37 /100
Moderate Beta 0.94x
EPS volatility 76.78%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MTVA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hyung Heon Kim
Employees
8
Headquarters
Cambridge
Upcoming events
05 NOV
Earnings
Upcoming earnings report